Muhammad Musab Zubair retweeted
CRRT vs intermittent renal replacement trial stopped early for concern of signal of worse mortality in intermittent group. You might need to read the conclusion a couple times though "intermittent hemodialysis was not noninferior to CRRT"
Presented at #LIVES2026:
An open-label, randomized, noninferiority trial showed that intermittent hemodialysis was not noninferior to continuous renal-replacement therapy in critically ill adults with acute kidney injury. Full ICRAKI trial results: nej.md/472QMel
Editorial: Continuous or Intermittent Renal-Replacement Therapy ā What is the Question? nej.md/4egLaB1

ALT A graph from the Original Article "Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury." The trial name, ICRAKI, is in parentheses after the title. The graph shows the cumulative probability of death from randomization through day 90, as estimated with the KaplanāMeier method. The trial results are being presented at the European Society of Intensive Care Medicine. The logo of the New England Journal of Medicine is at the bottom.
Excited to share insights from our ongoing #CRSBIDMC clinical trial, CRISP (Corticosteroids Reduced Inflammation in Severe Acute Pancreatitis), at the #ACG2026 Annual Meeting!
#ACG2026 #AcutePancreatitis
#CRSBIDMC
Muhammad Musab Zubair retweeted
Long COVID RCT results (n=126) as presented @ISLCPAIS in abstract form: PSRT had statistically significant & clinically meaningful improvement of primary endpt (somatic symptoms, SSS-8) & secondary endpts of fatigue, physical function, cognitive function, pain, & shortness of breath compared to two different control groups (usual care & mindfulness-based stress reduction [MBSR]). 1/2
Muhammad Musab Zubair retweeted
Call for papers on IHCA! Adult/pediatric topics welcome. Accepting a variety of article types. Click for more info:
š¢ Call for papers!
Submissions are open for "Advances in the Prevention and Management of In-Hospital Cardiac Arrest"
Edited by @drcatross @ryan_w_morgan and @Moskowcrit
Contribute or find out more ā”ļø fro.ntiers.in/77570
Excited to share our teamās work!
Post hoc analysis of the THICA and THACA trials suggests baseline cellular respiration may identify postācardiac arrest patients who benefit from thiamine therapy.
Published in Resuscitation. PMID: 41759812
#CardiacArrest #Thiamine
Muhammad Musab Zubair retweeted
Look forward to reading the new guideline for the evaluation and management of acute pulmonary embolism in adults.
No more submassive or massive it seems!
jacc.org/doi/10.1016/j.jacc.ā¦
Muhammad Musab Zubair retweeted
Great job @MuhammadMu10165 on presenting his work on CoQ10 and Lipoid acid in cardiac arrest! Increasea oxygen consumption in-vitro but can we translate this to in-vivo and then someday to outcomes? More work to come!
This quoted post is unavailable.
An unforgettable teaching moment !
During the debate on the 2025 AHA Guidelines for AFib with RVR, an audience member was called to demo what's missing in the guideline - a beautiful way of teaching !
#AHA2025
#Cardiology #cardiotwitter
#AHAReSS2025
Muhammad Musab Zubair retweeted
ā We are delighted to share that the International Liaison Committee on Resuscitation (ILCOR) general assembly has appointed Katherine M. Berg, MD as Co-Chair.
Read the full news here š bit.ly/48TOL6y
#ILCOR #resuscitation #ResuscitationScience
Muhammad Musab Zubair retweeted
I'll be doing the "con" of a debate at the AHA ReSS meeting in New Orleans on the broad topic of the new 2025 BLS/ACLS guidelines (link below). I have an idea of where I will go with this but want to hear yours - what controversies would you discuss? ahajournals.org/toc/circ/152ā¦
Magic or science? Iām not sureābut this will blow your mind. Watch and be amazed! š²āØ #MindReading #Mentalism
#Medicine
Grateful to be part of Dr. Mike Donnioās clinical trials and inspired by his mentorship. Highly recommend this video on manuscript writing ā a valuable resource for all researchers!
#MedTwitter #Research #AcademicWriting
Free talk on "Effective Manuscript Writing" if anyone is interested - this is part of a larger course in research but settings are such that anyone can log into the manuscript writing lecture for free - hope this helps! Happy to get feedback michael-donnino-s-school.teaā¦
Muhammad Musab Zubair retweeted
Congratulations to @KateMBerg for being elected Co-Chair of @Ilcor_org ! Well-deserved and will be great leadership for the organization. The CRS looks forward to her work in the years to come! Congrats Kate! @Moskowcrit @sarahmperman @NeumarRobert @sawyer_kn @jas_soar
Muhammad Musab Zubair retweeted
44 yr male w unknown PMH presents with confusion & abd pain. T98.1, HR110, BP108/60, RR28, Sat98%. Abd: diff tenderness. CBC=normal. Blood gas=lactate 27, pCO2=5, bicarb=3, pH 6.8. Glucose= 105, no ketones. HCT/abd CT/POCUS = negative. EKG=nl. Abx & 1L IVFs given. What next?
44%More IVF resuscitation
25%Exploratory Lap
0%Lumbar Puncture
31%Other test or Rx(add belo
16 votes ⢠Final results Muhammad Musab Zubair retweeted
Stanford paid 35,000 people to quit social media.
This was the largest study on emotional health in history.
The results were so shocking, scientists called it "comparable to therapy."
Here's what happens when you break free from the algorithm:
š§µ
Honored to present our Resuscitation Teamās clinical trial (led by Dr. Michael Donnino) on Coenzyme Q10 & Alpha-Lipoic Acid in out-of-hospital cardiac arrest at the #AHA annual meeting.
Grateful to my mentors Dr. Donnino, Xiaowen Liu & John Lee. #CRSBIDMC #IMResidencyMatch2025
Muhammad Musab Zubair retweeted
Donāt look for study advice online from strangers. You donāt know how they learn, what their goals are, or if their advice even works. They might be completely different from you. Instead, find people at your own school, students you know and trust, whose success you can verify firsthand. Their guidance will be more relevant, more reliable, and way less overwhelming. And you get to ignore all those endless online tips about what you āshouldā be doing. Just scroll past. Your sanity will thank you.























